Open an Account
search icon
3
NOTIFICATIONS
Best Algo trading app in India
Bigul

Bharat Parenterals Ltd - 541096 - Board Meeting Outcome for Outcome Of The Board Meeting And Submission Of Unaudited Financial Results For The Quarter And Half Year Ended 30Th September, 2022.

 In compliance of Regulation 30 and 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors of the Company in its meeting held on 12th November, 2022, has considered and approved the Unaudited Financial Results for the Quarter and half year ended 30th September, 2022 and taken on record Limited Review Report issued by the Statutory Auditors of the Company. In this respect, we hereby enclose following: 1. Unaudited Financial Results for the Quarter and Half year ended 30th September, 2022. 2. Limited Review Report on the said Financial Results.
12-11-2022
Bigul

Bharat Parenterals Ltd - 541096 - Update on board meeting

 Bharat Parenterals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2022 ,inter alia, to consider and approve Intimation of Meeting of Board of Directors for approval of Unaudited Financial Results for the Quarter and Half Year ended 30th September, 2022.
05-11-2022
Bigul

Bharat Parenterals Ltd - 541096 - Board Meeting Intimation for Intimation Of Meeting Of Board Of Directors For Approval Of Unaudited Financial Results For The Quarter Ended 30Th September, 2022.

 Bharat Parenterals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2022 ,inter alia, to consider and approve The unaudited financial results of the Company for the Quarter ended on September 30, 2022.
05-11-2022
Bigul

Bharat Parenterals Ltd - 541096 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

 We are enclosing herewith the Confirmation Certificate pursuant to provisions of Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018 duly sent and confirmed by Adroit Corporate Services Private Limited viz., Company's Registrar and Share Transfer Agent, registered with Securities and Exchange Board of India for the period ended on 30th September, 2022.
14-10-2022
Bigul

Bharat Parenterals Ltd - 541096 - Sub: Intimation Under Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015 ('SEBI Listing Regulations')

 In compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, following resolutions are approved in the 29th Annual General Meeting of the company held on 27th September, 2022: 1. Reappointment of Statutory Auditors CNK & Associates LLP, Chartered accountants (ICAI Firm Registration No. 101961) for the second term of 5 years. 2. Approval of material related party transactions. 3. Approval of Increase in Authorized Share Capital of the company by Rs. 50,00,000/- (Rupees Fifty Only) divided into 5,00,000 (Five Lakhs) Equity Shares of Rs. 10/- (Rupees Ten Only) each and alteration of Memorandum of Association of the Company. 4. Reappointment of Mrs. Zankhana Sheth, Independent Director of the company. 5. Approval of Loans, Investment, Guarantee or security to be made under section 185 of Companies Act, 2013 to subsidiary company 'Varenyam Biolifesciences Private Limited'
14-10-2022
Bigul

Bharat Parenterals Ltd - 541096 - Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of Association

 In compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, following resolutions are approved in the 29th Annual General Meeting of the company held on 27th September, 2022
11-10-2022
Bigul

Bharat Parenterals Ltd - 541096 - Statement Of Investor Complaints For The Quarter Ended September 2022

 No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Lubhanshi JhalaniDesignation :- Company Secretary and Compliance Officer
10-10-2022
Bigul

Bharat Parenterals Ltd - 541096 - Closure of Trading Window

 Sub: Closure of Trading Window Pursuant to Company's Code of Conduct framed in accordance with the SEBI (Prohibition of Insider Trading) Regulations, 2015 as amended, the Trading Window for dealing in the securities of the company for all designated persons specified under the Code shall remain close form 01st October, 2022 onwards till 48 hours after the declaration of Unaudited Financial Results for the quarter ended 30thSeptember, 2022 (both days inclusive). Accordingly, all designated persons have been advised not to trade in the securities of the company during the aforesaid period of Closure of Trading window.
30-09-2022
Bigul

Bharat Parenterals Ltd - 541096 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report

 Pursuant to regulation 44 of SEBI (Listing Obligation and Disclosure Requirements) Regulations,2015 as amended, enclosed herewith the details of Voting results and Scrutinizer Report of 29th Annual General Meeting of the company held through Video Conferencing or Other Audio-Visual Means (OAVM) on 27th September,2022 at 10:30 A.M.
28-09-2022
Bigul

Bharat Parenterals Ltd - 541096 - Shareholder Meeting / Postal Ballot-Outcome of AGM

 As per the requirement of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, proceedings of the 29th Annual General Meeting held on 27th September, 2022 through Video Conferencing (VC)/other audio visual means (OAVM) of the Company is enclosed herewith.
27-09-2022
Next Page
Close

Let's Open Free Demat Account